|
1
|
Agulnik M and Epstein JB: Nasopharyngeal
carcinoma: Current management, future directions and dental
implications. Oral Oncol. 44:617–627. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee AW, Lin JC and Ng WT: Current
management of nasopharyngeal cancer. Semin Radiat Oncol.
22:233–244. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Spano JP, Busson P, Atlan D, Bourhis J,
Pignon JP, Esteban C and Armand JP: Nasopharyngeal carcinomas: An
update. Eur J Cancer. 39:2121–2135. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vokes EE, Liebowitz DN and Weichselbaum
RR: Nasopharyngeal carcinoma. Lancet. 350:1087–1091. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
August M, Dodson TB, Nastri A and Chuang
SK: Nasopharyngeal carcinoma: Clinical assessment and review of 176
cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
91:205–214. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen W and Hu GH: Biomarkers for enhancing
the radiosensitivity of nasopharyngeal carcinoma. Cancer Biol Med.
12:23–32. 2015.PubMed/NCBI
|
|
7
|
Wolff HA, Rödel RM, Gunawan B, Overbeck T,
Herrmann MK, Hennies S, Hille A, Vorwerk H, Matthias C, Hess CF and
Christiansen H: Nasopharyngeal carcinoma in adults: Treatment
results after long-term follow-up with special reference to
adjuvant interferon-beta in undifferentiated carcinomas. J Cancer
Res Clin Oncol. 136:89–97. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chou J, Lin YC, Kim J, You L, Xu Z, He B
and Jablons DM: Nasopharyngeal carcinoma-review of the molecular
mechanisms of tumorigenesis. Head Neck. 30:946–963. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen ZT, Liang ZG and Zhu XD: A Review:
Proteomics in nasopharyngeal carcinoma. Int J Mol Sci.
16:15497–15530. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Razak AR, Siu LL, Liu FF, Ito E,
O'Sullivan B and Chan K: Nasopharyngeal carcinoma: The next
challenges. Eur J Cancer. 46:1967–1978. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tulalamba W and Janvilisri T:
Nasopharyngeal carcinoma signaling pathway: An update on molecular
biomarkers. Int J Cell Biol. 2012:5946812012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Morris KV and Mattick JS: The rise of
regulatory RNA. Nat Rev Genet. 15:423–437. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yarmishyn AA and Kurochkin IV: Long
noncoding RNAs: A potential novel class of cancer biomarkers. Front
Genet. 6:1452015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ulitsky I and Bartel DP: lincRNAs:
Genomics, evolution, and mechanisms. Cell. 154:26–46. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Saxena A and Carninci P: Long non-coding
RNA modifies chromatin: Epigenetic silencing by long non-coding
RNAs. Bioessays. 33:830–839. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang W, Wang L, Zheng F, Zou R, Xie C,
Guo Q, Hu Q, Chen J, Yang X, Yao H, et al: Long noncoding RNA
expression signatures of metastatic nasopharyngeal carcinoma and
their prognostic value. Biomed Res Int. 2015:6189242015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Maruyama R and Suzuli H: Long noncoding
RNA involvement in cancer. BMB Rep. 45:604–611. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu T, Su B, Wang C, Wang S, Huang H, Pan
Y, Wang D, Wei W, Claret FX and Yang H: Molecular markers to assess
short-term disease local recurrence in nasopharyngeal carcinoma.
Oncol Rep. 33:1418–1426. 2015.PubMed/NCBI
|
|
20
|
Su YJ, Yu J, Huang YQ and Yang J:
Circulating long noncoding RNA as a potential target for prostate
cancer. Int J Mol Sci. 16:13322–13338. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Weber DG, Johnen G, Casjens S, Bryk O,
Pesch B, Jöckel KH, Kollmeier J and Brüning T: Evaluation of long
noncoding RNA MALAT1 as a candidate blood-based biomarker for the
diagnosis of non-small cell lung cancer. BMC Res Notes. 6:5182013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gao W, Chan JY and Wong TS: Differential
expression of long noncoding RNA in primary and recurrent
nasopharyngeal carcinoma. Biomed Res Int. 2014:4045672014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou X, Cui J, Macias V, Kajdacsy-Balla
AA, Ye H, Wang J and Rao PN: The progress on genetic analysis of
nasopharyngeal carcinoma. Comp Funct Genomics. 2007:575132007.
View Article : Google Scholar
|
|
24
|
Edge SB and Compton CC: The America joint
committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chang ET and Adami HO: The enigmatic
epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol
Biomarkers Prev. 15:1765–1777. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kimura Y, Suzuki D, Tokunaga T,
Takabayashi T, Yamada T, Wakisaka N, Yoshizaki T, Murata H, Miwa K,
Shoujaku H, et al: Epidemiological analysis of nasopharyngeal
carcinoma in the central region of Japan during the period from
1996 to 2005. Auris Nasus Larynx. 38:244–249. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Young LS and Dawson CW: Epstein-Barr virus
and nasopharyngeal carcinoma. Chin J Cancer. 33:581–590.
2014.PubMed/NCBI
|
|
29
|
Wapinski O and Chang HY: Long noncoding
RNAs and human disease. Trends Cell Biol. 21:354–361. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qiu MT, Hu JW, Yin R and Xu L: Long
noncoding RNA: An emerging paradigm of cancer research. Tumour
Biol. 34:613–620. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Quan M, Chen J and Zhang D: Exploring the
secrets of long noncoding RNAs. Int J Mol Sci. 16:5467–5496. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rinn JL and Chang HY: Genome regulation by
long noncoding RNAs. Annu Rev Biochem. 81:145–166. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yao Y, Li J and Wang L: Large intervening
non-coding RNA HOTAIR is an indicator of poor prognosis and a
therapeutic target in human cancers. Int J Mol Sci. 15:18985–18999.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang J, Zhang P, Wang L, Piao HL and Ma
L: Long non-coding RNA HOTAIR in carcinogenesis and metastasis.
Acta Biochim Biophys Sin (Shanghai). 46:1–5. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li Z, Zhao X, Zhou Y, Liu Y, Zhou Q, Ye H,
Wang Y, Zeng J, Song Y, Gao W, et al: The long non-coding RNA
HOTTIP promotes progression and gemcitabine resistance by
regulating HOXA13 in pancreatic cancer. J Transl Med. 13:842015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yan TH, Yang H, Jiang JH, Lu SW, Peng CX,
Que HX, Lu WL and Mao JF: Prognostic significance of long
non-coding RNA PCAT-1 expression in human hepatocellular carcinoma.
Int J Clin Exp Pathol. 8:4126–4131. 2015.PubMed/NCBI
|
|
37
|
De Decker HP and Lawrenson JB: The 22q11.2
deletion: From diversity to a single gene theory. Genet Med. 3:2–5.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Brinchi V, Curatolo P, Di Franco C and
Dallapiccola B: 2 new cases of chromosome 22 with ring structure.
Pathologica. 71:3691979.(In Italian). PubMed/NCBI
|
|
39
|
Schneider M and Eliez S: 22q11.2
microdeletion. Arch Pediatr. 17:431–434. 2010.(In French).
View Article : Google Scholar : PubMed/NCBI
|
